Engineered type 2 cytokine signalling to improve car-t cell effector functions
The invention relates to chimeric antigen receptor constructs and their use for treatments and therapies. Further disclosed are methods of treating and/or preventing a disease, such as e.g. a cancer, an infectious disease, an inflammatory or inflammation-induced disease, a chronic disease or an autoimmune disease.
89897856
Signalisation de cytokine de type 2 modifiée pour améliorer les fonctions effectrices de cellules car-t
École Polytechnique Fédérale de Lausanne
Alternative title(s) : (de) Manipulierte typ-2-cytokinsignalisierung zur verbesserung der car-t-zelleffektorfunktionen (fr) Signalisation de cytokine de type 2 modifiée pour améliorer les fonctions effectrices de cellules car-t
6.2502
| Identifier | Country code | Kind code | Date issued |
WO2025168766 | WO | A1 | 2025-08-14 |
EP4600264 | EP | A1 | 2025-08-13 |